Evidence Hub

Exploring the mechanism of active ingredients of Smilacis Glabrae Rhizoma in treating migraine headache through network pharmacology and animal experiments

D. Shu, Yanyan Chen, Jiao Wang, Ying Wang, Yong Gu, Yan-Xin Wang

Integrative Medicine Discovery, 2024

Abstract

Background : To explore the potential mechanism of action of the active ingredients of Smilacis Glabrae Rhizoma (SGR) in the treatment of migraine using network pharmacology and in vivo experiments. Methods: Through the search of Traditional Chinese Medicines Systems Pharmacology Database and Analysis Platform, Genecards, Drugbank and other databases, we obtained active ingredients, targets of SGR and related disease targets of migraine, and took the intersection for protein-protein interactions analysis. After constructing the network diagram, network topology analysis was performed to derive the core targets and key active ingredients, and Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed. Finally, molecular docking was performed and validated by in vivo experiments. In vivo experiments, 18 male BALB/c mice were selected, and the SGR group was fed with SGR drinking tablet concentrate, and nitroglycerin injection was used to construct a mouse model of migraine. Enzyme-linked immunosorbent assay test was used to detect the levels of TNF-α, IL-1β, IL-6, and AKT1 in plasma. Results: The results showed that the core targets of SGR for the treatment of migraine were TNF-α, IL-1β, IL-6, and AKT1. These core targets and key active ingredients had better binding ability. Compared with the blank group, the number of head scratching in the model group increased. Compared with the model group, there was a significant reduction of…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free